Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Satinder K Sandhu Added: 3 years ago
Over the last three decades numerous transcatheter therapies for the treatment of congenital heart disease (CHD) have been developed. Interatrial Septal Defect Balloon atrial septostomy has been performed in patients with transposition physiology and in patients where egress of blood is needed from the left or the right atrium and in adults with pulmonary vascular disease where the creation of… View more
Author(s): Tullio Palmerini , Carlo Savini , Marco Di Eusanio Added: 3 years ago
Neurological dysfunction following coronary artery bypass graft (CABG) surgery can manifest as stroke, encephalopathy including delirium and post-operative cognitive dysfunction. Stroke is one of the most devastating complications after CABG surgery, entailing permanent disability and a 3–6 fold increased risk of death with a case-fatality rate up to 20 %.1,2 It is also associated with… View more
Author(s): Timothy Glenie , Peter Ruygrok Added: 3 years ago
Abstract As the treatment of acute myocardial infarction has evolved from conservative management to thrombolysis and, in more recent times, primary angioplasty, the incidence of ventricular rupture, in particular post-infarction ventricular septal defect (VSD), appears to have fallen. In this article we discuss the clinical presentation and investigation of post-infarction VSD, the natural… View more
Author(s): Yusuke Watanabe , Makoto Nakashima Added: 3 years ago
Transcatheter aortic valve implantation (TAVI) has become a commonly used and minimally invasive approach for patients with severe aortic stenosis (AS).1,2 In the latest guidelines from the 2017 European Society of Cardiology (ESC)/European Association for Cardio-Thoracic Surgery (EACTS) for the management of valvular heart disease, the following clinical characteristics favour TAVI: Society of… View more
Author(s): Jean-Pierre Bassand Added: 3 years ago
Anticoagulants and antiplatelet therapies, and revascularisation/ reperfusion with percutaneous coronary interventions (PCIs) or surgery are the mainstay of modern treatment of acute coronary syndromes (ACS) with and without ST-segment elevation. In addition, depending on the clinical presentation, thrombolytic therapy may be necessary in patients with ST-elevation myocardial infarction (MI) who… View more